Skip to main content
SGMOQ logo

SGMOQ · Sangamo Therapeutics, Inc

Track SGMOQ — free
$0.17 -0.01 (-3.83%) At close · Aug 17
Market Cap
$69.72M
Shares
414.29M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024
Executive Total
Alexander D. Macrae $2,457,450
Prathyusha Duraibabu $1,186,045
Scott B. Willoughby $1,139,794
Nathalie Dubois-Stringfellow $1,132,369
Fiscal 2023
Executive Total
Alexander D. Macrae $2,392,272
D. Mark McClung $1,116,596
Prathyusha Duraibabu $1,057,465
Nathalie Dubois-Stringfellow $1,027,105
Jason Fontenot $972,242
Fiscal 2022
Executive Total
Alexander D. Macrae $4,806,435
D. Mark McClung $1,674,251
R. Andrew Ramelmeier $1,499,589
Jason Fontenot $1,414,648
Prathyusha Duraibabu $1,293,430
Fiscal 2021
Executive Total
Alexander D. Macrae $4,735,817
Robert J. Schott $1,899,465
R. Andrew Ramelmeier $1,690,594
D. Mark McClung $1,657,289
Prathyusha Duraibabu $1,056,750
Sung H. Lee $47,956
Fiscal 2020
Executive Total
Alexander D. Macrae $3,835,030
D. Mark McClung $2,671,226
R. Andrew Ramelmeier $1,534,700
Sung H. Lee $1,442,217
Stéphane Boissel $1,433,976
Gary H. Loeb $1,393,313
Fiscal 2019
Executive Total
Alexander D. Macrae $3,986,555
Sung H. Lee $2,530,680
Adrian Woolfson $2,310,510
Gary H. Loeb $2,043,025
Stéphane Boissel $1,485,282
R. Andrew Ramelmeier $1,104,540
Kathy Y. Yi $1,069,587
Fiscal 2018
Executive Total
Alexander D. Macrae $4,104,428
Corporate Strategy $2,590,066
Stéphane Boissel $2,590,066
Kathy Y. Yi $1,266,580
Fiscal 2017
Executive Total
Alexander D. Macrae $1,795,856
Kathy Y. Yi $994,005

Executive changes

Person Change Filed
Nikunj Jain Appointed 2026-02-03
Prathyusha Duraibabu Terminated 2026-02-03
Nikunj Jain Appointed 2025-09-30
Prathyusha Duraibabu Resigned 2025-09-30
Prathyusha Duraibabu Resigned 2025-09-11
Karen L. Smith Appointed 2024-06-05
H. Stewart Parker Appointed 2024-06-05
James R. Meyers Appointed 2024-06-05
John H. Markels Appointed 2024-06-05
Alexander D. Macrae Appointed 2024-06-05
Margaret A. Horn Appointed 2024-06-05
Kenneth J. Hillan Appointed 2024-06-05
Robert F. Carey Appointed 2024-06-05
Courtney Beers Appointed 2024-06-05
Karen L. Smith, M.D., Ph.D., M.B.A., L.L.M. Appointed 2023-06-02
John H. Markels, Ph.D. Appointed 2023-06-02
James R. Meyers Appointed 2023-06-02
H. Stewart Parker Appointed 2023-06-02
Alexander D. Macrae, M.B., Ch.B., Ph.D. Appointed 2023-06-02
Margaret A. Horn, J.D. Appointed 2023-06-02
Kenneth J. Hillan, M.B. Appointed 2023-06-02
Robert F. Carey Appointed 2023-06-02
Courtney Beers, Ph.D. Appointed 2023-06-02
Phillip Ramsey Appointed 2023-04-26
R. Andrew Ramelmeier, Ph.D. Terminated 2023-04-26
Key facts CIK 1001233 CUSIP 800677106 13F (30d) 8 filings 8 filers Visit website Investor relations